Selected Case Studies and Impurity Strategies for Drug Substances Part I: Introduction to PGIs

Posted by

Regis Technologies, Inc.

Regis' Director of Analytical Method Development, Dr. Paul Wrezel, repurposes his Pittcon 2015 talk for a Regis audience. In this first part of three, he gives an overview of Potential Genotoxic Impurities (PGIs) and the ICH guidelines concerning them.